Latest Financing News

Talonx Resources has secured shareholder approval for two high-grade gold project acquisitions and extinguished $4.7 million in legacy debt, while completing drilling at its Viking Gold Project with assay results due soon.

Boab Metals is set to accelerate construction at its fully funded Sorby Hills Silver-Lead Project in 2026, capitalising on silver prices currently three times higher than previous assumptions. The company aims for first concentrate production by mid-2027, supported by strategic drilling and corporate milestones.

Wia Gold has appointed mining veteran Henk Diederichs as Managing Director and CEO, signaling a strategic shift as the Kokoseb Gold Project in Namibia moves toward a Definitive Feasibility Study.

Amaero Ltd has lowered its FY2026 revenue guidance due to delayed U.S. government contracts but reports strong contracted revenue and a robust cash position heading into 2026.

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

Polymetals Resources has resumed operations at its Endeavor Mine following a tragic incident, completing first concentrate shipments and securing $34.4 million in new capital to support exploration and ramp-up.

Magnum Mining and Exploration Limited has launched a $7 million capital raising via a placement of shares accompanied by 630 million new options exercisable at $0.015, set to expire in three years. The offer aims to bolster working capital and advance exploration projects across the US and Brazil.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

AVITA Medical reported solid 11% revenue growth in 2025 and secured a $60 million credit facility to fuel its next phase of expansion, projecting up to 19% revenue growth in 2026.